CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


10-June-2014
New Snap-N-Spike® Therapeutic Drug Monitoring (TDM) Standards from Cerilliant -  Busulfan and 5-Fluorocytosine.

5-Fluorocytosine, 2.0 mg/mL, F-030
2.0 mg/mL in Methanol

5-Fluorocytosine, sold under the trade name Ancobon®, is an antifungal drug used in the treatment and prevention of superficial and systemic fungal infections. This Certified Spiking Solution® is suitable as starting material for calibrators, controls, or linearity standards for therapeutic drug monitoring or clinical and diagnostic testing of 5-fluorocytosine in patient blood, serum, or plasma samples by HPLC or LC-MS/MS.

Busulfan, 1.0 mg/mL, 1 mL B-058
1.0 mg/mL in Methanol

Used in the treatment of cancer, busulfan is an alkylating antineoplastic drug monitored by clinical labs to ensure patients remain within the drug’s therapeutic range. Adverse reactions to busulfan include vomiting, anorexia, anemia, infertility and bone marrow suppression. 




Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn